Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence

Journal of Hospital Infection

Volumn 85, Issue 1, 2013, Pages 17-21

  Islam, J ^a   Cheek, E ^b   Navani, V ^a   Rajkumar, C ^c   Cohen, J ^a   Llewelyn, M J ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile infection (CDI); Cohort ward; Recurrence

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT TRANSPORT; RECURRENT INFECTION; REINFECTION; RISK FACTOR; URINARY TRACT INFECTION;

EID: 84881662144     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.06.009     Document Type: Article

References (19)

1. Freeman J., Bauer M.P., Baines S.D., et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010, 23:529-549.
2. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
3. Eyre D.W., Walker A.S., Wyllie D., et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012, 55(Suppl. 2):S77-S87.
4. Clostridium difficile infection: how to deal with the problem 2009, Department of Health, DoH, London.
5. Health and Social Care Act 2008: Code of practice for health and adult social care on the prevention and control of infections and related guidance 2009, Department of Health, DoH, London.
6. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
7. Johnson S., Adelmann A., Clabots C.R., Peterson L.R., Gerding D.N. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. JInfect Dis 1989, 59:340-343.
8. Tang-Feldman Y., Mayo S., Silva J., Cohen S.H. Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile-associated diarrhea. JClin Microbiol 2003, 41:3413-3414.
9. O'Neill G.L., Beaman M.H., Riley T.V. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991, 107:627-635.
10. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., Petit J.C. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. JClin Microbiol 2000, 38:2386-2388.
11. Wilcox M.H., Fawley W.N., Settle C.D., Davidson A. Recurrence of symptoms in Clostridium difficile infection - relapse or reinfection?. JHosp Infect 1998, 38:93-100.
12. Price J., Cheek E., Lippett S., et al. Impact of an intervention to control Clostridium difficile infection on hospital and community onset disease; an interrupted time series analysis. Clin Microbiol Infect 2010, 16:1297-1302.
13. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
14. Wilson V., Cheek E., Satta G., et al. Predictors of death following Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010, 50:e77-e81.
15. Dubberke E.R., Reske K.A., Yan Y., Olsen M.A., McDonald L.C., Fraser V.J. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007, 45:1543-1549.
16. Sethi A.K., Al-Nassir W.N., Nerandzic M.M., Bobulsky G.S., Donskey C.J. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C.difficile infection. Infect Control Hosp Epidemiol 2010, 31:21-27.
17. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L., Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007, 45:992-998.
18. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007, 28:140-145.
19. Figueroa I., Johnson S., Sambol S.P., Goldstein E.J., Citron D.M., Gerding D.N. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 2012, 55(Suppl. 2):S104-S109.